Hansvdz schreef op 22 december 2020 16:54:
Ocugen (NASDAQ:OCGN) rises 11% premarket after signing a binding letter of intent (LOI) with Bharat Biotech to co-develop Bharat's COVID-19 vaccine candidate, COVAXIN, an advanced stage whole-viron inactivated vaccine candidate, for the U.S. market.